QED Clinical Services has recently joined forces with QED Partnership, another highly experienced UK based CRO. The coming together of the two companies under the QED Clinical Services umbrella means that the merged organization can now provide further expertise, capacity and enhanced quality in the conduct of clinical trials. The two companies were already long term partners, sharing many similarities and hence this is a highly complementary pairing. The resulting enhanced QED Clinical Services organization can now draw on the vast experience of new Senior Management team members, such as Susan Ollier, BSc, MRQA, HonFICR, CSci and David Ollier BSc, MICR. Susan was previously the chair of the Institute of Clinical Research (ICR) for 2 years and a member of the ICR Board for 6 years and David has an extensive clinical background with focus on working closely with the NHS. The QED Partnership team also bring a diverse customer base ranging from large pharmaceutical sponsors to small Biotech which complement the numerous existing QED Clinical sponsors. Furthermore the team possess a wealth of experience in Research Governance, Auditing and Training within the NHS which will allow QED Clinical to expand its non-commercial sponsor business significantly.